GlassScriptPhysician profile
Florian E Toegel
NPI 1154555704
$1,439.41
in general payments reported to CMS, 2019-2025
11 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.97 · 2020: $13.90 · 2021: $25.59 · 2022: $864 · 2023: $35.90 · 2024: $303 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,073.13 | 2022-2025 | Symplicity G3, Ellipsys Vascular Access System |
| Astrazeneca Pharmaceuticals LP | $109.93 | 2024 | Farxiga |
| Mozarc Medical US LLC | $51.03 | 2023-2025 | Chameleon, Palindrome, Permcath |
| W. L. Gore & Associates, INC. | $45.55 | 2024-2025 | Gore Viabahn Endoprosthesis |
| Angiodynamics, INC. | $39.70 | 2022-2023 | Duramax |
| Celgene Corporation | $25.59 | 2021 | |
| Lemaitre Vascular, INC. | $22.97 | 2019 | |
| Cordis US Corp. | $21.95 | 2024 | Saber |
| Bard Peripheral Vascular, INC. | $18.97 | 2024 | Covera |
| Argon Medical Devices, INC. | $16.69 | 2024 | Clot Management |
| Covidien LP | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florian Toegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.